We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Shark-Derived Antibodies in Alzheimer’s Disease Therapy

Product News   Feb 06, 2017 | Original Story From Biolegend

 
Shark-Derived Antibodies in Alzheimer’s Disease Therapy

Biolegend

FURTHER INFORMATION
 
 
 

Related Product News

BioMed X Starts New Schizophrenia Research Program with Boehringer Ingelheim

Product News

BioMed X is collaborating with Boehringer Ingelheim to investigate myelination deficits of the adolescent brain in connection with the development of schizophrenia.

READ MORE

Selonterra To Present Alzheimer’s Disease Therapy Program at Biotech Showcase™ 2020

Product News

Selonterra, a biotechnology company with the aim of discovering therapies for neurodegenerative disorders by harnessing human genetics and gene regulatory networks, has announced a presentation at the Biotech Showcase™ 2020.

READ MORE

3D Cell Culture Scaffolds Provide New Insights Into Myelination

Product News

Scientists at Stanford University Medical School have used the Mimetix® aligned 3D cell culture scaffold supplied by AMSBIO to understand the architecture of the myelin sheaths which insulate neuronal axons.

READ MORE

Like what you just read? You can find similar content on the communities below.

Neuroscience

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE